Trial Profile
A multi-center, open-label extension study to evaluate the long-term safety, tolerability, and efficacy of E2007 (perampanel) in patients with painful diabetic neuropathy (PDN) or post-herpetic neuralgia (PHN).
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 21 Jun 2019
Price :
$35
*
At a glance
- Drugs Perampanel (Primary)
- Indications Diabetic neuropathies; Neuropathic pain; Postherpetic neuralgia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Eisai Co Ltd; Eisai Inc
- 11 Apr 2019 This trial has been completed in Hungary, according to European Clinical Trials Database.
- 15 Mar 2012 This trial is recruiting in Hungary and England.
- 15 Mar 2012 Additional locations (England, Germany, Hungary, Lithuania) added as reported by European Clinical Trials Database.